This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Migrata UK Ltd.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Annika Eriksson: Innovator in Hemoglobin Determination
Introduction
Annika Eriksson is a notable inventor based in Helsingborg, Sweden. She has made significant contributions to the field of medical diagnostics, particularly in the determination of hemoglobin levels in blood samples. Her innovative approach has the potential to enhance the accuracy and efficiency of blood analysis.
Latest Patents
Annika holds a patent for an "Analysis method and cuvette therefor," which describes a method for hemoglobin determination. This method involves introducing a sample of undiluted whole blood into a disposable microcuvette through capillary action. The microcuvette contains a dry, non-hygroscopic hemolysing agent that dissolves in the blood, hemolyses the red blood cells, and releases the hemoglobin. The process includes performing a first absorption measurement at a wavelength range of 490-520 nm directly on the sample, followed by a second measurement to compensate for background interference. This innovative method simplifies the process of hemoglobin analysis and improves diagnostic accuracy.
Career Highlights
Annika Eriksson is associated with Migrata UK Ltd., where she continues to develop her innovative ideas. Her work has garnered attention in the medical field, showcasing her commitment to advancing healthcare technology. With her expertise, she has contributed to the development of tools that can significantly impact patient care.
Collaborations
Annika collaborates with talented individuals such as Johnny Svensson and Sven-Erik L Nilsson. Their combined efforts in research and development have led to advancements in medical diagnostics, particularly in blood analysis technologies.
Conclusion
Annika Eriksson is a pioneering inventor whose work in hemoglobin determination is making waves in the medical diagnostics field. Her innovative methods and dedication to improving healthcare technology are commendable.